Synapse

← Stephan Windecker

Papers by Stephan Windecker

Page 2 · newest first

  1. Updated Standardized Endpoint Definitions for Transcatheter Aortic Valve ImplantationJournal of the American College of Cardiology · 2012
  2. Baseline anaemia and short dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary interventionEuropean Journal of Preventive Cardiology · 2026
  3. Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarctionEuropean Heart Journal · 2016
  4. Mechanisms of Very Late Bioresorbable Scaffold ThrombosisJournal of the American College of Cardiology · 2017
  5. Very Late Scaffold ThrombosisJournal of the American College of Cardiology · 2015
  6. Value of the SYNTAX Score for Risk Assessment in the All-Comers Population of the Randomized Multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) TrialJournal of the American College of Cardiology · 2010
  7. Transcatheter Mitral Valve Replacement for Degenerated Bioprosthetic Valves and Failed Annuloplasty RingsJournal of the American College of Cardiology · 2017
  8. Three-Year Results From the Evolve Ii Randomized Trial: Late Clinical Outcomes With Bioresorbable Compared to Permanent Polymer Everolimus-ElutingJournal of the American College of Cardiology · 2017
  9. Short and medium chain acylcarnitines as markers of outcome in diabetic and non-diabetic subjects with acute coronary syndromesEuropean Heart Journal · 2020
  10. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trialEuropean Heart Journal · 2016
  11. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factorsEuropean Heart Journal · 2016
  12. Great debate: transcatheter aortic valve implantation should also be performed in non-surgical centresEuropean Heart Journal · 2025
  13. Bicuspid Aortic Valve Morphology and Outcomes After Transcatheter Aortic Valve ReplacementJournal of the American College of Cardiology · 2020
  14. Recurrent Events Analysis of MASTER DAPTJournal of the American College of Cardiology · 2025
  15. Interventional cardiology in Europe 1994European Heart Journal · 1998
  16. Impact of Transcatheter or Surgical Aortic Valve Performance on 5-Year Outcomes in Patients at ≥ Intermediate RiskJournal of the American College of Cardiology · 2025
  17. P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary EventsJournal of the American College of Cardiology · 2023
  18. Frequency distribution of collateral flow and factors influencing collateral channel developmentJournal of the American College of Cardiology · 2001
  19. Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary SyndromeJournal of the American College of Cardiology · 2019
  20. Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trialThe Lancet · 2023
  21. Rates and predictors of hospital readmission after transcatheter aortic valve implantationEuropean Heart Journal · 2017
  22. Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary StentingJournal of the American College of Cardiology · 2019
  23. Clinical outcomes of patients with low-flow, low-gradient, severe aortic stenosis and either preserved or reduced ejection fraction undergoing transcatheter aortic valve implantationEuropean Heart Journal · 2013
  24. Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary SyndromesJournal of the American College of Cardiology · 2018
  25. Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trialsEuropean Heart Journal · 2022
  26. Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve DiseaseJournal of the American College of Cardiology · 2014
  27. Predictors of Permanent Pacemaker Implantation in Patients With Severe Aortic Stenosis Undergoing TAVRJournal of the American College of Cardiology · 2014
  28. Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)Journal of the American College of Cardiology · 2019
  29. Management of Conduction Disturbances Associated With Transcatheter Aortic Valve ReplacementJournal of the American College of Cardiology · 2019
  30. Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical TrialsJournal of the American College of Cardiology · 2011
  31. Prevention, Diagnosis, and Management of Radiation-Associated Cardiac DiseaseJournal of the American College of Cardiology · 2019
  32. Biomimetic transcatheter aortic valve replacement restores ascending aortic flow towards native physiology: A first-in-human prospective imaging studyEuropean Heart Journal - Valvular and Structural Heart Disease · 2026
  33. Thirty-day outcomes of a novel biomimetic balloon-expandable transcatheter heart valve in patients with small aortic annuliEuroIntervention · 2026
  34. Obstructive Coronary Artery Disease and Health Status in Transcatheter Aortic Valve ReplacementJAMA Network Open · 2025
  35. Transcatheter Treatment of Bicuspid Aortic Valve Stenosis: From Observational Studies to Randomized Clinical TrialsSHILAP Revista de lepidopterología · 2025
  36. Revascularization in Ischemic Left Ventricular DysfunctionJACC: Cardiovascular Interventions · 2025
  37. Left Atrial Appendage Occlusion Using the Amplatzer Amulet Device in High-Risk Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Intervention: A Randomized Pilot StudyStructural Heart · 2025
  38. Mechanical circulatory support in high-risk elective PCI: rationale and design of the PROTECT IV trial.2025
  39. Long-Term Outcomes in Moderate and Severe Aortic Stenosis According to Extent of Cardiac DamageJACC: Cardiovascular Interventions · 2025
  40. Recommended methodologies for clinical investigations of high-risk medical devices—Conclusions from the European Union CORE–MD ProjectThe Lancet Regional Health - Europe · 2025
  41. CT assessment of right heart anatomy across tricuspid regurgitation severity grades: implications for transcatheter interventionsThe International Journal of Cardiovascular Imaging · 2025
  42. Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: the DEDICATE-DZHK6 trialEuropean Heart Journal · 2025
  43. Management of Bicuspid Aortic StenosisOxford Academic · 2025
  44. Noninvasive Anatomical and Functional Imaging for Hemodynamic Relevance in Right Coronary Artery AnomaliesJAMA Cardiology · 2025
  45. Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve StenosisCirculation · 2025
  46. Interdisciplinary periprocedural management of patients undergoing transapical tmvi with the tendyne™ system: A narrative review and institutional experience.2025
  47. Intake of high-intensity statin after acute myocardial infarction assessed by direct drug concentration measurement: association with LDL-C response and coronary plaque modifications in the PACMAN-AMI trialEuropean Journal of Preventive Cardiology · 2025
  48. Educational level, clinical outcomes and quality of care in a Swiss cohort of patients with acute coronary syndromesEuropean Journal of Clinical Investigation · 2025
  49. Colchicine in patients with aortic stenosis undergoing transcatheter aortic valve replacement: a double-blind randomized trialNature Communications · 2025
  50. Impact of Noncoaxial Transcatheter Aortic Valve Implantation on Clinical OutcomesJACC Advances · 2025